As a part of our comprehensive treatment program, these FDA-approved medications will help more people get and stay healthy
Muscle-Preserving Results
38 GLP-1RAs increase microvascular blood flow in muscle tissue, enhance myocyte metabolism, inhibit muscle atrophy, and improve muscle mass and function
Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose
RECENT ARTICLES Fitness GLP-1 and Strength Training: Avoiding a Common Pitfall Losing weight on a GLP-1 medication
Strategic fill-finish capacity was simultaneously secured through Novo Holdings' $16.5 billion acquisition of CDMO giant Catalent, through which Novo Nordisk gained three dedicated fill-finish manufacturing sites in Anagni, Italy, Brussels, Belgium, and Bloomington, Indiana, employing more than 3,000 people